4-Hydroxyamphetamine
| 4-HA | |
|---|---|
| Salts [] | |
|---|---|
| 4-Hydroxyamphetamine hydrobromide | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 151.21 g/mol [1] |
| Predicted LogP | 1.4 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C9H13NO |
| IUPAC name | 4-(2-aminopropyl)phenol |
| SMILES | CC(CC1=CC=C(C=C1)O)N |
| InChI | InChI=1S/C9H13NO/c1-7(10)6-8-2-4-9(11)5-3-8/h2-5,7,11H,6,10H2,1H3 |
| InChIKey | GIKNHHRFLCDOEU-UHFFFAOYSA-N |
| CAS number | 103-86-6 |
| UNII | FQR280JW2N |
| PubChem CID | 3651 |
| Pharmacokinetics[] | |
|---|---|
| Routes of administration | Eye drops |
4-Hydroxyamphetamine (also known as hydroxyamphetamine, Norveritol, Pulsoton, Oxamphetaminium, Oksamfetamin, Oxamfetamin, Paredrinex, Nov-Pholedrin, p-(2-Aminopropyl)phenol or Phenol, p-(2-aminopropyl)-) is a sympathomimetic substance of the amphetamine class.
Chemistry
Salts []
4-Hydroxyamphetamine is typically found in the form of its hydrobromide salt.
Stereochemistry []
4-Hydroxyamphetamine is a racemic mixture of the enantiomers (optical activity ( + / - )).
Druglikeness
Lipinski's rule of five
4-Hydroxyamphetamine matches Lipinski's rule of five.Pharmacology
Mechanism of action []
Hydroxyamphetamine hydrobromide is an indirect acting sympathomimetic agent which causes the release of norepinephrine from adrenergic nerve terminals, resulting in mydriasis. [1]
Subjective effects []
Legal status []
- Other: 4-Hydroxyamphetamine is a Rx-only.
See also []
External links []
- 4-Hydroxyamphetamine (Wikipedia)
- 4-Hydroxyamphetamine (PubChem)
- 4-Hydroxyamphetamine (Wikidata)
- 4-Hydroxyamphetamine (DrugBank)
- 4-Hydroxyamphetamine (ChEMBL)
- 4-Hydroxyamphetamine (ChEBI)
- 4-Hydroxyamphetamine (Common Chemistry)
- 4-Hydroxyamphetamine (HMDB)
- 4-Hydroxyamphetamine (EPA DSSTox)
- 4-Hydroxyamphetamine (Effect Index)
- 4-Hydroxyamphetamine (UNII)
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 3651, 4-Hydroxyamphetamine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/3651
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. 4-Hydroxyamphetamine. UNII: FQR280JW2N. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/FQR280JW2N
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 07:12:44 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 07:12:40 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 07:12:40 |
| gsrs | ok | 2026-11-20 07:12:41 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0060765) | 2026-11-20 07:12:40 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 07:12:44 |
| pubchem | ok | 2026-11-20 07:12:39 |
| missing (no r/tripreports posts mention it) | 2026-11-20 07:12:40 | |
| sider | missing (not in SIDER) | 2026-11-20 07:12:40 |
| structure | ok | 2026-11-20 07:12:40 |
| wikipedia | ok | 2026-11-20 07:12:40 |